These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries. Bourgain RH, Andries R, Decuyper K, De Clerck F. J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488 [Abstract] [Full Text] [Related]
24. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist. Vaghi F, Colombo M, Pierucci L, Volpi D, Dho L, Ukmar G, Rosa B, Salvati P. Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268 [Abstract] [Full Text] [Related]
29. The in vitro effect of ridogrel on platelet function in normocholesterolaemic and familial hypercholesterolaemic type IIa subjects. Naran NH, Chetty N. Thromb Res; 1997 Dec 01; 88(5):399-407. PubMed ID: 9556227 [Abstract] [Full Text] [Related]
30. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro. De Clerck F, Beetens J, de Chaffoy de Courcelles D, Freyne E, Janssen PA. Thromb Haemost; 1989 Feb 28; 61(1):35-42. PubMed ID: 2546278 [Abstract] [Full Text] [Related]
31. Effects of ridogrel on the prostacyclin-thromboxane ratio in nulliparous third trimester-pregnant rhesus monkeys. Keith JC, Goodrich JA, Endo Y, Taub D, Mehlman P, Ward G. Prostaglandins; 1993 Jun 28; 45(6):547-55. PubMed ID: 8337414 [Abstract] [Full Text] [Related]
32. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms. Xavier FE, Davel AP, Fukuda LE, Rossoni LV. J Hypertens; 2009 Jun 28; 27(6):1233-42. PubMed ID: 19337130 [Abstract] [Full Text] [Related]
33. Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs. Seeger W, Obernitz R, Thomas M, Walmrath D, Suttorn N, Holland IB, Grimminger F, Eberspächer B, Hugo F, Bhakdi S. Am Rev Respir Dis; 1991 Apr 28; 143(4 Pt 1):797-805. PubMed ID: 1826193 [Abstract] [Full Text] [Related]
34. Thromboxane and prostacyclin production in the perfused rabbit lung. Peeters FA, Van den Bossche R, Bult H, Herman AG. Prostaglandins Leukot Essent Fatty Acids; 1991 Aug 28; 43(4):239-46. PubMed ID: 1946551 [Abstract] [Full Text] [Related]
37. Cyclooxygenase products from endogenous arachidonic acid in isolated dog and rabbit lungs. Littner MR, Lott FD. Am Rev Respir Dis; 1988 Aug 28; 138(2):383-8. PubMed ID: 3143287 [Abstract] [Full Text] [Related]
38. The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage. Imura Y, Terashita Z, Nishikawa K. Thromb Res; 1990 Jul 01; 59(1):195-205. PubMed ID: 2119075 [Abstract] [Full Text] [Related]
39. The glutathione redox cycle as a defense system against hydrogen-peroxide-induced prostanoid formation and vasoconstriction in rabbit lungs. Seeger W, Suttorp N, Schmidt F, Neuhof H. Am Rev Respir Dis; 1986 Jun 01; 133(6):1029-36. PubMed ID: 3087249 [Abstract] [Full Text] [Related]